MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy shows promise against tough cancers
Disease control CompletedThis early-phase trial tested an experimental immunotherapy called ELI-002 in 25 people with KRAS-mutated pancreatic, colorectal, lung, ovarian, or bile duct cancers who had minimal residual disease after standard treatment. The goal was to see if the treatment is safe and can re…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
Immune cells take on tough leukemia in early trial
Disease control CompletedThis early-phase study tested a new treatment using lab-grown immune cells (NK cells) in 2 adults with acute myeloid leukemia (AML) that had come back or not responded to standard therapy. The main goal was to see if the treatment is safe and tolerable. Researchers also looked fo…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 15:26 UTC
-
New immunotherapy targets hidden leukemia cells to prevent relapse
Disease control CompletedThis study tested a drug called blinatumomab in 36 adults with B-cell acute lymphoblastic leukemia who were in remission but still had tiny amounts of cancer cells (minimal residual disease). The goal was to see if the drug could clear those leftover cells and help patients stay …
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC